XML 43 R29.htm IDEA: XBRL DOCUMENT v3.20.4
3. Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Fair Value Disclosures [Abstract]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following table provides a reconciliation of the Level 3 contingent consideration liabilities measured at estimated fair value (in millions):
December 31, 2019$4.9 
Analytical flow cytometer platform:
Payment of sales milestone (3.3)
Net decrease in estimated fair value of contingent consideration included in Selling, general and administrative expense(1.0)
Foreign distributor earn-outs:
Change in estimated fair value of contingent consideration included in Selling, general and administrative expense— 
Celsee, Inc.:
Fair value of contingent consideration0.1 
December 31, 2020$0.7 
 
Debt Securities, Available-for-sale [Table Text Block]
Available-for-sale investments consist of the following (in millions):
 December 31, 2020
Amortized
Cost
Unrealized
Gains
Unrealized
Losses
Allowances for Credit LossesEstimated
Fair
Value
Short-term investments:    
Corporate debt securities$130.5 $2.7 $— — $133.2 
Municipal obligations15.0 0.2 — — 15.2 
Asset-backed securities35.8 0.3 — — 36.1 
U.S. government sponsored agencies74.7 2.2 — — 76.9 
Foreign government obligations4.0 — — — 4.0 
  Other foreign obligations 2.1 — — — 2.1 
 262.1 5.4 — — 267.5 
Long-term investments:    
Asset-backed securities0.1 — — — 0.1 
 0.1 — — — 0.1 
Total$262.2 $5.4 $— $— $267.6 
Available-for-sale investments consist of the following (in millions):
 December 31, 2019
Amortized
Cost
Unrealized
Gains
Unrealized
Losses
Estimated
Fair
Value
Short-term investments:    
Corporate debt securities$203.2 $1.4 $(0.1)$204.5 
Municipal obligations11.5 0.1 — 11.6 
Asset-backed securities72.7 0.2 (0.1)72.8 
U.S. government sponsored agencies105.6 0.7 (0.2)106.1 
Foreign government obligations4.7 — — 4.7 
  Other foreign obligations3.1 — — 3.1 
 400.8 2.4 (0.4)402.8 
Long-term investments:    
Asset-backed securities0.1 — — 0.1 
 0.1 — — 0.1 
Total$400.9 $2.4 $(0.4)$402.9 
Summary of amortized cost and estimated fair value of debt securities by contractual maturity date
The following is a summary of the amortized cost and estimated fair value of our debt securities at December 31, 2020 by contractual maturity date (in millions):
Amortized
Cost
Estimated Fair
Value
Mature in less than one year$130.9 $131.5 
Mature in one to five years88.1 90.5 
Mature in more than five years43.2 45.6 
Total$262.2 $267.6 
 
Summary of investments with gross unrealized losses and the associated fair value
The following is a summary of investments with gross unrealized losses and the associated fair value (in millions):

There were no significant unrealized losses as of December 31, 2020 in either the less than or greater than 12 month categories.

Gross unrealized losses and associated fair value (in millions) as of December 31, 2019 were:

December 31, 2019
Less than 12 monthsGreater than 12 monthsTotal
Description of securities:Fair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized Losses
Corporate debt securities$46.5 $0.1 $2.1 $— $48.6 $0.1 
Asset-backed securities17.9 — 7.0 0.1 24.9 0.1 
U.S. government sponsored agencies27.5 0.2 10.8 — 38.3 0.2 
Total$91.9 $0.3 $19.9 $0.1 $111.8 $0.4 
 
Schedule of Derivative Instruments [Table Text Block]
The following is a summary of our forward foreign currency exchange contracts (in millions):
 December 31,
 2020
Contracts maturing in January through March 2021 to sell foreign currency: 
Notional value$125.3 
Unrealized loss$(0.4)
Contracts maturing in January through March 2021 to purchase foreign currency: 
Notional value$301.6 
Unrealized gain$0.4 
 
Estimated fair value of financial instruments
The estimated fair value of our long-term debt and the level of the fair value hierarchy within which the fair value measurement is categorized are as follows (in millions):
 December 31, 2020December 31, 2019
Carrying 
Amount 
Estimated 
Fair 
Value 
Fair Value Hierarchy LevelCarrying 
Amount 
Estimated 
Fair 
Value 
Fair Value Hierarchy Level
Total current maturities long-term debt, excluding leases$— $— N/A$424.4 $435.5 2
 
Fair Value Measurements, Recurring and Nonrecurring
Financial assets and liabilities carried at fair value and measured on a recurring basis as of December 31, 2020 are classified in the hierarchy as follows (in millions):
Level 1Level 2Level 3Total
Financial assets carried at fair value:   
Cash equivalents:   
Commercial paper$— $41.7 $— $41.7 
Time deposits17.6 10.0 — 27.6 
Asset-backed securities— 0.9 — 0.9 
U.S. government sponsored agencies— 2.5 — 2.5 
Money market funds60.1 — — 60.1 
Total cash equivalents (a)77.7 55.1 — 132.8 
Restricted investments (b)6.7 — — 6.7 
Equity Securities (c)9,582.4 — — 9,582.4 
Available-for-sale investments:
Corporate debt securities— 133.2 — 133.2 
U.S. government sponsored agencies— 76.9 — 76.9 
Foreign government obligations— 4.0 — 4.0 
Other foreign obligations— 2.1 — 2.1 
Municipal obligations— 15.2 — 15.2 
Asset-backed securities— 36.2 — 36.2 
Total available-for-sale investments (d)— 267.6 — 267.6 
Forward foreign exchange contracts (e)— 1.0 — 1.0 
Total financial assets carried at fair value$9,666.8 $323.7 $— $9,990.5 
Financial liabilities carried at fair value:   
     Forward foreign exchange contracts (f)$— $1.0 $— $1.0 
     Contingent consideration (g)— — 0.7 0.7 
Total financial liabilities carried at fair value$— $1.0 $0.7 $1.7 

Financial assets and liabilities carried at fair value and measured on a recurring basis as of December 31, 2019 are classified in the hierarchy as follows (in millions):
Level 1Level 2Level 3Total
Financial assets carried at fair value:   
Cash equivalents:   
Commercial paper$— $42.9 $— $42.9 
Time deposits31.2 10.0 — 41.2 
Asset-backed securities— 0.1 — 0.1 
Money market funds69.9 — — 69.9 
Total cash equivalents (a)101.1 53.0 — 154.1 
Restricted investments (b)5.6 — — 5.6 
Equity securities (c)4,664.4 — — 4,664.4 
Available-for-sale investments:   
Corporate debt securities— 204.5 — 204.5 
U.S. government sponsored agencies— 106.1 — 106.1 
Foreign government obligations— 4.7 — 4.7 
Other foreign obligations— 3.1 — 3.1 
Municipal obligations— 11.6 — 11.6 
Asset-backed securities— 72.9 — 72.9 
Total available-for-sale investments (d)— 402.9 — 402.9 
Forward foreign exchange contracts (e)— 0.9 — 0.9 
Total financial assets carried at fair value$4,771.1 $456.8 $— $5,227.9 
Financial liabilities carried at fair value:   
Forward foreign exchange contracts (f)$— $1.0 $— $1.0 
 Contingent consideration (g)— — 4.9 4.9 
Total financial liabilities carried at fair value$— $1.0 $4.9 $5.9 

(a) Cash equivalents are included in Cash and cash equivalents in the consolidated balance sheets.

(b) Restricted investments are included in the following accounts in the consolidated balance sheets (in millions):
December 31, 2020December 31, 2019
Restricted investments$5.6 $5.6 
Other investments1.1— 
   Total$6.7 $5.6 


(c) Equity securities are included in the following accounts in the consolidated balance sheets (in millions):
December 31, 2020December 31, 2019
Short-term investments$61.4 $51.0 
Other investments9,521.0 4,613.4 
   Total$9,582.4 $4,664.4 

The change in fair market value on our equity securities for the year ended December 31, 2020 was $4,495.8 million gain, which was primarily due to our investment in Sartorius AG and is recorded in our consolidated statements of income.
As of December 31, 2020, we own 12,987,900 ordinary voting shares and 9,588,908 preference shares of Sartorius AG (Sartorius), of Goettingen, Germany, a process technology supplier to the biotechnology, pharmaceutical, chemical and food and beverage industries. We did not purchase any incremental shares for the years ended December 31, 2020 and 2019. We own approximately 37% of the ordinary outstanding voting shares (excluding treasury shares) and 28% of the preference shares of Sartorius as of December 31, 2020. The Sartorius family trust and Sartorius family members hold a controlling interest of the outstanding voting shares. We do not have any representative or designee on Sartorius' board of directors, nor do we have the ability to exercise significant influence over the operating and financial policies of Sartorius.


(d) Available-for-sale investments are included in the following accounts in the consolidated balance sheets (in millions):
 December 31,
2020
December 31, 2019
Short-term investments$267.5 $402.8 
Other investments0.1 0.1 
Total$267.6 $402.9 


(e) Forward foreign exchange contracts in an asset position are included in other current assets in the consolidated balance sheets.

(f) Forward foreign exchange contracts in a liability position are included in other current liabilities in the consolidated balance sheets.

(g) Contingent consideration liabilities are included in the following accounts in the consolidated balance sheets (in millions):
December 31, 2020December 31, 2019
Other current liabilities$0.6 $3.3 
Other long-term liabilities0.1 1.6 
   Total$0.7 $4.9